Device Manufacturers

Last week news was released after months of speculation, that the FDA would consider the de novo classification option for digital pathology systems as a pathway for bringing to market a moderate or low risk device which has not yet been...

Collaboration with FDA Results in Opportunity for Streamlined Approval Process The Digital Pathology Association (DPA) announced today that it suggests digital pathology manufacturers currently interested in marketing whole slide imaging (WSI)...

New trial is open to patients who have completed standard treatments; Goal is to determine if cancer recurrences can be detected earlier and lead to improved targeted outcomes. Cynvenio Biosystems, Inc., a diagnostics company dedicated to...

Since the inception of commercially available whole slide imaging systems more than 15 years ago, a necessary requirement has been to prove that diagnoses made using DP alone are equal to or better than conventional glass slides (GS) that have...

The American Society for Clinical Pathology (ASCP), the world’s largest professional membership organization for pathologists and laboratory professionals, has paved the way to digital pathology with the creation of ASCPedia, an innovative...

This live webinar is all about the way Philips sees the future of the pathology lab, as well as how we tackle any challenges together with our customers. Sharing multiplies your knowledge. This simple statement might look obvious. But is...